Tag: Emgality

Clinical trials for Emgality (galcanezumab) have largely found no significant difference in weight changes between patients and those on a placebo. Despite this data, many patients taking this CGRP inhibitor for migraine prevention still ask: **Does Emgality cause weight gain?**

According to the Migraine Trust, calcitonin gene-related peptide (CGRP) monoclonal antibodies were the first medicines specifically designed to prevent migraine attacks. This newer class of drugs provides a definitive answer to the question, **what is the monthly injection for migraines?**, offering a proactive solution for people with frequent or chronic migraines.